Is Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Proving The Doubters Wrong?

PRIMECAP Management Co. has recently announced that it has increased stake in Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) by 0.77%. After grabbing 18.38 million shares, the institutional investor is now in possession of 0.14 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.77% having worth around $1.63 billion. Moreover, […]